期刊文献+

活动期溃疡性结肠炎患者血清瘦素与ghrelin水平的临床分析

Serum leptin and ghrelin levels in patients with active ulcerative colitis
原文传递
导出
摘要 目的研究活动期溃疡性结肠炎(UC)患者血清瘦素及ghrelin水平变化情况及其临床意义。方法纳入54例活动期uc患者和25例正常对照,采用ELISA法检测所有入选者的血清瘦素及ghre-lin水平,并与UC患者的主要临床病理特征进行相关性分析。采用营养风险筛查2002(NRS2002)筛查活动期UC患者的营养风险。结果活动期UC患者的血清瘦素[(245.51±129.72)比(183.80-4-59.67)pg/ml,P:0.029]及ghrelin水平[(1477.964-501.86)比(1188.00±474.51)pg/ml,P=0.041]均显著高于正常对照组。UC患者血清瘦素(r=0.715,P=0.019)、ghrelin水平(r=0.667,P:0.027)与疾病严重程度相关,但与疾病临床类型、病变范围、内镜分级不相关(P均〉0.05)。有营养风险UC患者的血清瘦素[(332.82±172.92)比(194.15±49.71)pg/ml,P:0.026]及ghrelin水平[(1848.60±326.48)比(1259.93±459.24)pg/ml,P=0.021]均显著高于无营养风险uc患者。结论活动期uc患者血清瘦素及ghrelin水平增高,且与uc患者病情严重程度、营养风险相关。 Objective To investigate the change of serum leptin and ghrelin levels in patients with active ulcerative colitis (UC) and their clinical significance. Methods Fiftyfour patients with active UC and 25 normal controls were enrolled in this study, and serum levels of leptin and ghrelin were determined by enzymelinked immu nosorbent absorption. The correlations between serum leptin/ghrelin and the main clinicopathological features of pa tients with active UC were analyzed. The nutritional status of these patients were assessed by using the Nutritional Risk Screening 2002 ( NRS 2002). Results The serum levels of leptin and ghrelin in patients with active UC were significantly higher than those in normal controls [ leptin: (245.51 + 129.72 ) vs. ( 183. 80 ~ 59.67 ) pg/ml, P = 0. 029 ; ghrelin: ( 1477.96 :t: 501.86) vs. ( 1188.00 _+ 474.51 ) pg/ml, P = 0. 0d1 ] ; and both of them were corre lated with the disease severity ( leptin : r = 0. 715, P = 0. 019 ; ghrelin : r = 0. 667, P = O. 027 ), but were not corre lated with the clinical type, the extent of lesion, and the endoscopic grading (all P 〉 0. 05). In the UC patients with nutritional risk, the serum levels of leptin and ghrelin were also significantly higher than those in subjects without nutritionalrisk [leptin: (332.82_+172.92) vs. (194.15_+49.71) pg/ml, P=0.026; ghrelin: (1848.60_+ 326.48) vs. (1259.93_+459.24) pg/ml, P=O. 021]. Conclusion Patients with active UC have remarkably higher serum leptin and ghrelin levels, which is associated with the disease severity and the nutritional risk.
出处 《中华临床营养杂志》 CAS 2012年第1期10-14,共5页 Chinese Journal of Clinical Nutrition
关键词 溃疡性结肠炎 瘦素 GHRELIN 炎症性肠病 Ulcerative colitis Leptin Ghrelin Inflammatory bowel disease
  • 相关文献

参考文献24

  • 1Goh J, O'Morain CA. Review article: nutrition and adult inflamma- tory bowel disease [ J]. Aliment Pharmacol Ther, 2003, 17 ( 3 ) : 307-320.
  • 2高永健,朱峰,钱家鸣,于康,陈伟.112例炎症性肠病患者的营养风险筛查[J].中华临床营养杂志,2009,17(6):324-327. 被引量:27
  • 3Nguyen GC, Munsell M, Harris ML. Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie mal- nutrition in hospitalized inflammatory bowel disease patients [ J ]. In- flamm Bowel Dis, 2008, 14(8) :1105-1111.
  • 4Karmiris K, Koutroubakis IE, Xidakis C, et al. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel dis- ease [J]. Inflamm Bowel Dis, 2006, 12(2) :100-105.
  • 5Ates Y, Degertekin B, Erdil A, et al. Serum ghrelin levels in in- flammatory bowel disease with relation to disease activity and nutri- tional status [J]. Dig Dis Sci, 2008, 53(8) :2215-2221.
  • 6中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1020
  • 7谭琰,邹开芳,杨天,陈胜,侯晓华,潘庆华.微生态制剂对溃疡性结肠炎患者治疗前后临床疗效观察[J].中华消化内镜杂志,2008,25(2):77-81. 被引量:50
  • 8Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutri- tion screening 2002 [J]. Clin Nutr, 2003, 22(4) :415-421.
  • 9Ahima RS, Flier JS. Leptin [J]. Annu Rev Physiol, 2000, 62 (3) :413-437.
  • 10Martin-Romero C, Santos-Alvarez J, Gobema R, et al. Human lep- tin enhances activation and proliferation of human circulating T lym- phocytes [ J]. Cell Immunol, 2000, 199( 1 ) :15-24.

二级参考文献39

  • 1Bibiloni R, Fedorak RN, Tannock GW, et al. VSL#3 probioticmixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol,2005,100 : 1539 -1546.
  • 2Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1 ) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut ,2005,54:242-249.
  • 3Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update) : American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol,2004, 99:1371-1385.
  • 4Pullan RD, Rhodes J, Ganesh S,et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med,1994,330:811-815.
  • 5Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis, 2004, 10:286- 299.
  • 6Guarner C, Runyon BA, Young S,et al. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol, 1997,26 : 1372-1378.
  • 7Fiocchi C. Microbial factors in the pathogenesis of IBD. Bioscience Microflora,2003 ,22 :5-14.
  • 8Marteau P, Lepage P, Mangin I, et al. gut flora and inflammatory bowel disease. Aliment Phannacol Ther,2004,20( Suppl 4) : 18- 23.
  • 9Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition [J]. FASEB J, 2001, 15(14) : 2565-2571.
  • 10Martin-Romero C, Santos-Alvarez J, Goberna R, et al. Human leptin enhances activaton and proliferation of human circulating T lymphocytes [J]. Celllmmunol, 2000, 199(1): 15-24.

共引文献1137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部